The Mets have made a move that wouldn’t help them in 2022, as they signed John Curtiss to a major league deal. Curtiss is currently rehabbing from his TJS and will miss the entire 2022 season. The Mets made this move for his cheap team option in 2023. He is signed for 770.000 this year with a 775.000 team option.

Fun play by Rays relief pitcher John Curtiss pic.twitter.com/C7PwDydM8c

— Talkin’ Baseball (@TalkinBaseball_) October 14, 2020

In 2022 Curtiss pitched to a 3.45 ERA after a 2.48 ERA with the Marlins, before he got hurt. In 44.1 innings, he pitched to a 3.82FIP and 1.23 WHIP. The 29 year old righty has a 2.89 ERA in 71.2 innings since 2019.

This is a very smart move by the Mets. Worst case scenario is losing close to 1.5 mil, but if the rehab goes well they added a solid reliever without spending a lot. With some prime Mets relievers in their last season before hitting free agency, this could be a very important move.

A healthy John Curtiss would be a nice get for the #Mets next year. Fastball up to 98 with a good slider.

Curtiss pitched under Billy Eppler with the Angels in 2019 before moving on to the Rays where he really blossomed in 2020. pic.twitter.com/Xy0ompMY7w

— Jacob Resnick (@Jacob_Resnick) April 6, 2022

The Mets also made some other moves as they put Chasen Shreve and Travis Jankowski on the 40 man roster. Both will make the team out of spring training. To make room, the Mets DFA’d Travis Blankenhorn and Jordan Yamamoto

Photo Credit: MLB Trade Rumors